Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Loading
Home›
Research›
Investment Firms›
Uncommon Denominator
AddedFeb 13, 2024
UpdatedJun 28, 2026
Uncommon Denominator

Uncommon Denominator

Operating

Venture capital firm investing in consumer brands, software companies, and frontier technologies with unique skill-spikes.

Location
New York City, NY, US
Founded
2018
Firm
Compare
Portfolio
Employees
Website

Investments

Kanvas Biosciences
Kanvas Biosciences

Total Raised

$12M

Rounds

1

Seed$12MJune 2023
Dandi Technologies
Dandi Technologies

Total Raised

$3.7M

Rounds

1

Seed$3.7MOctober 2022
Mytide Therapeutics
Mytide Therapeutics

Total Raised

$7.5M

Rounds

4

Series A$7MMarch 2022
Series UnknownJanuary 2021
Alba Orbital
Alba Orbital

Total Raised

$3.4M

Rounds

2

Seed$3.4MMay 2021
Upsie
Upsie

Total Raised

$26.4M

Rounds

7

Series A$18.2MMay 2021
Sanctuary
Sanctuary

Total Raised

$6.5M

Rounds

3

Seed$3MMay 2021
Seed$2MOctober 2019
Vincent
Vincent

Total Raised

$8M

Rounds

4

Seed$2MDecember 2020
Liquid Death
Liquid Death

Total Raised

$200.6M

Rounds

7

Series B$23MSeptember 2020
PaymentWorks
PaymentWorks

Total Raised

$20.2M

Rounds

5

Series Unknown$1.8MApril 2020
Nomic Bio
Nomic Bio
Series A

Total Raised

$18.2M

Rounds

6

Seed$150kMarch 2020
Allstacks
Allstacks

Total Raised

$21.1M

Rounds

7

Seed$4.7MDecember 2019
Truman's
Truman's

Total Raised

$5M

Rounds

1

Seed$5MSeptember 2019
Envizzo
Envizzo

Total Raised

$5.4M

Rounds

2

Seed$4.5MJune 2019
Culture Biosciences
Culture Biosciences

Total Raised

$101.6M

Rounds

8

Series Unknown$5.5MFebruary 2019
Order
Order

Total Raised

$44.7M

Rounds

5

Seed$4.6MAugust 2018
Burrow
Burrow
Acquired

Total Raised

$53.3M

Rounds

8

Series A$14MMarch 2018
Reverie Labs
Reverie Labs
Series A

Total Raised

$25.1M

Rounds

3

Seed$120kMarch 2018
MegaBots
MegaBots

Total Raised

$6.3M

Rounds

3

Series UnknownJanuary 2018